Abstract:AIM: To investigate the effects of atorvastatin on the apoptosis of vascular smooth muscle cells(VSMCs), and probe into the significance of expression of apoptosis inhibitor Survivin. METHODS: The experiment was performed in the National Key Laboratory for Medical Genetics, central laboratory of Xiangya Second Hospital of Central South University from April 2004 to March 2005. 1 The VSMCs were derived from the middle layers of aortas in 5 one-month-old healthy male rats which had been cultured for 5 or 6 passages. Sterile cover glass was placed in the 6-well culture plate before intervention, and the VSMCs were treated in 4 groups when they grew up to 90% of the whole cover glass: normal control group not treated with atorvastatin, atorvastatin 0.1 μmol/L group treated with 0.1 μmol/L atorvastatin, atorvastatin 1 μmol/L group treated with 1 μmol/L atorvastatin, and atorvastatin 10 μmol/L group treated with 10 μmol/L atorvastatin. 2 The apoptosis of VSMCs was ob-served at 6, 12, 24, 48 and 72 hours after atorvastatin treatment by Hoechst33258 fluorescence staining. The expression of Survivin protein in VSMCs was detected by means of immunohistochemistry. 3 Inter-group difference was performed by t test.RESULTS: 1 From the results of fluorescence staining for the detection of VSMC apoptosis, the apoptotic VSMCs were increased in a dose- and time-dependent manner after they were treated with atorvastatin. At 72 hours af-ter treatment with atorvastatin, the apoptosis rate of VSMCs was signifi-cantly higher in the atorvastatin 0.1 μmol/L, 1 μmol/L, 10 μmol/L groups than in the normal control group(11.1%, 27.2%, 50.5% vs 3.8%, P < 0.01), and it was also significantly different in the inter-group comparison(P < 0.01). 2 The expression of Survivin protein in VSMCs was decreased at 24 hours after treated with atorvastatin, and was not detected in VSMCs at 48 hours to 72 hours after treated with atorvastatin. CONCLUSION: 1 Atorvastatin can induce the apoptosis of VSMCs in dose- and time-dependent manners. 2 The mechanisms of atorvastatin in- ducing apoptosis of VSMCs may be associated with down-regulating expres-sion of Survivin protein.

Inhibitory effect of atorvastatin on AGE-induced HCAEC apoptosis by upregulating HSF-1 protein

[Effects of Atorvastatin on P27 Protein Expression and Cardiomyocytes Apoptosis in Spontaneously Hypertensive Rats].

Atorvastatin inhibits the H2O2-induced apoptosis of human vascular endothelial cells through a down-regulation of cleaved caspase-9/caspase-3

Autophagy plays a protective role in advanced glycation end product-induced apoptosis of vascular endothelial cells

Inhibitive Effects of Atorvastatin on Homocysteine-Induced Endoplasmicreticulum Stress in Human Umbilical Vein Endothelial Cells

Atorvastatin Inhibits Homocysteine-Induced Dysfunction and Apoptosis in Endothelial Progenitor Cells.

Atorvastatin Attenuates Homocysteine-Induced Apoptosis in Human Umbilical Vein Endothelial Cells Via Inhibiting NADPH Oxidase-Related Oxidative Stress-Triggered P38mapk Signaling

Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products.

ATORVASTATIN DELAY THE SENESCENCE OF VASCULAR ENDOTHELIAL CELL INDUCED BY ANGIOTENSINII THROUGH REGULATING THE EXPRESSION OF BCL-2/BAX PROTEIN

The Effects of Atorvastatin on Left Ventricular Remodeling in Spontaneously Hypertensive Rats

Atorvastatin exerts inhibitory effect on endothelial senescence in hyperlipidemic rats through a mechanism involving down-regulation of miR-21-5p/203a-3p

Atorvastatin inhibits homocysteine-induced endoplasmic reticulum stress through activation of AMP-activated protein kinase.

Atorvastatin inhibits the expression of RAGE induced by advanced glycation end products on aortas in healthy Sprague–Dawley rats

Effect of atorvastatin on AGEs-induced injury of cerebral cortex via inhibiting NADPH oxidase -NF-κB pathway in ApoE-/- mice

Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK.

Atorvastatin Inhibit the Apoptosis of Human Umbilical Vein Endothelial Cells Induced by High Glucose Through Regulating the Expression of Bcl-2/Bax Protein

Atorvastatin Blocks Advanced Glycation End Products Induced Reduction in Macrophage Cholesterol Efflux Mediated with ATP-Binding Cassette Transporters G 1

Atorvastatin Reverses the Dysfunction of Human Umbilical Vein Endothelial Cells Induced by Angiotensin II.

Interventional effects of atorvastatin on the apoptosis of vascular smooth muscle cells

Synergistic effects of homocysteine acid and advanced glycation end products on the apoptosis of vascular endothelial cells

Atorvastatin Inhibiting Homocysteine-Induced Oxidative Stress and Apoptosis in Human Umbilical Vein Endothelial Cells Involving NADPH Oxidase and P38mapk